Curtis L Triplitt

  • 1734 Citations
  • 23 h-Index
20012020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

  • 1734 Citations
  • 23 h-Index
  • 39 Article
  • 14 Review article
  • 2 Editorial
  • 1 Chapter
Filter
Article
2020

Combination therapy with canagliflozin plus liraglutide exerts additive effect on weight loss, but not on HbA1c, in patients with type 2 diabetes

Ali, A. M., Martinez, R., Al-Jobori, H., Adams, J., Triplitt, C., DeFronzo, R., Cersosimo, E. & Abdul-Ghani, M., Jun 1 2020, In : Diabetes care. 43, 6, p. 1234-1241 8 p.

Research output: Contribution to journalArticle

Open Access
1 Scopus citations

Evidence against an important role of plasma insulin and glucagon concentrations in the increase in EGP caused by SGLT2 inhibitors

Alatrach, M., Laichuthai, N., Martinez, R., Agyin, C., Ali, A. M., Al-Jobori, H., Lavynenko, O., Adams, J., Triplitt, C., DeFronzo, R., Cersosimo, E. & Abdul-Ghani, M., Apr 1 2020, In : Diabetes. 69, 4, p. 681-688 8 p.

Research output: Contribution to journalArticle

Open Access

Increase in endogenous glucose production with SGLT2 inhibition is unchanged by renal denervation and correlates strongly with the increase in urinary glucose excretion

Solis-Herrera, C., Daniele, G., Alatrach, M., Agyin, C., Triplitt, C., Adams, J., Patel, R., Gastaldelli, A., Honka, H., Chen, X., Abdul-Ghani, M., Cersosimo, E., Prato, S. D. & DeFronzo, R., May 1 2020, In : Diabetes care. 43, 5, p. 1065-1069 5 p.

Research output: Contribution to journalArticle

2018

Empagliflozin Treatment Is Associated with Improved β -Cell Function in Type 2 Diabetes Mellitus

Al Jobori, H., Daniele, G., Adams, J., Cersosimo, E., Solis-Herrera, C., Triplitt, C., Defronzo, R. A. & Abdul-Ghani, M., Apr 1 2018, In : Journal of Clinical Endocrinology and Metabolism. 103, 4, p. 1402-1407 6 p.

Research output: Contribution to journalArticle

13 Scopus citations

Endogenous glucose production and hormonal changes in response to canagliflozin and liraglutide combination therapy

Martinez, R., Al-Jobori, H., Ali, A. M., Adams, J., Abdul-Ghani, M., Triplitt, C., DeFronzo, R. A. & Cersosimo, E., Jun 1 2018, In : Diabetes. 67, 6, p. 1182-1189 8 p.

Research output: Contribution to journalArticle

15 Scopus citations
2017

Combination Therapy with Exenatide Plus Pioglitazone Versus Basal/Bolus Insulin in Patients with Poorly Controlled Type 2 Diabetes on Sulfonylurea Plus Metformin: The Qatar Study

Abdul-Ghani, M., Migahid, O., Megahed, A., Adams, J., Triplitt, C., DeFronzo, R. A., Zirie, M. & Jayyousi, A., Mar 1 2017, In : Diabetes care. 40, 3, p. 325-331 7 p.

Research output: Contribution to journalArticle

19 Scopus citations

Determinants of the increase in ketone concentration during SGLT2 inhibition in NGT, IFG and T2DM patients

Al Jobori, H., Daniele, G., Adams, J., Cersosimo, E., Triplitt, C. L., Defronzo, R. A. & Abdul-ghani, M. A., Jun 1 2017, In : Diabetes, Obesity and Metabolism. 19, 6, p. 809-813 5 p.

Research output: Contribution to journalArticle

25 Scopus citations

Empagliflozin and kinetics of renal glucose transport in healthy individuals and individuals with type 2 diabetes

Al-Jobori, H., Daniele, G., Cersosimo, E., Triplitt, C., Mehta, R., Norton, L., DeFronzo, R. A. & Abdul-Ghani, M., Jul 1 2017, In : Diabetes. 66, 7, p. 1999-2006 8 p.

Research output: Contribution to journalArticle

22 Scopus citations

How similar are biosimilars? What do clinicians need to know about biosimilar and follow-on insulins?

Triplitt, C. L., Hinnen, D. & Valentine, V., Oct 1 2017, In : Clinical Diabetes. 35, 4, p. 209-216 8 p.

Research output: Contribution to journalArticle

4 Scopus citations

Inhibition of renal sodium-glucose cotransport with empagliflozin lowers fasting plasma glucose and improves β-cell function in subjects with impaired fasting glucose

Abdul-ghani, M. A., Al Jobori, H., Daniele, G., Adams, J., Cersosimo, E., Triplitt, C. L. & Defronzo, R. A., Sep 1 2017, In : Diabetes. 66, 9, p. 2495-2502 8 p.

Research output: Contribution to journalArticle

5 Scopus citations
2016

Exenatide improves both hepatic and adipose tissue insulin resistance: A dynamic positron emission tomography study

Gastaldelli, A., Gaggini, M., Daniele, G., Ciociaro, D., Cersosimo, E., Tripathy, D., Triplitt, C. L., Fox, P. T., Musi, N., Defronzo, R. A. & Iozzo, P., Dec 1 2016, In : Hepatology. 64, 6, p. 2028-2037 10 p.

Research output: Contribution to journalArticle

32 Scopus citations
2015

Canagliflozin treatment in patients with type 2 diabetes mellitus

Triplitt, C. L. & Cornell, S., 2015, In : Clinical Medicine Insights: Endocrinology and Diabetes. 8, p. 73-81 9 p., A012.

Research output: Contribution to journalArticle

7 Scopus citations

Empagliflozin and linagliptin combination therapy for treatment of patients with type 2 diabetes mellitus

Triplitt, C. L., Solis-Herrera, C., Cersosimo, E., Abdul-ghani, M. A. & Defronzo, R. A., Nov 20 2015, (Accepted/In press) In : Expert Opinion on Pharmacotherapy. p. 1-15 15 p.

Research output: Contribution to journalArticle

14 Scopus citations

Exenatide regulates cerebral glucose metabolism in brain areas associated with glucose homeostasis and reward system

Daniele, G., Iozzo, P., Molina-Carrion, M., Lancaster, J. L., Ciociaro, D., Cersosimo, E., Tripathy, D., Triplitt, C. L., Fox, P. T., Musi, N., Defronzo, R. A. & Gastaldelli, A., Oct 1 2015, In : Diabetes. 64, 10, p. 3406-3412 7 p.

Research output: Contribution to journalArticle

26 Scopus citations

GLP-1 Receptor Agonists: Practical Considerations for Clinical Practice

Triplitt, C. & Solis-Herrera, C., Dec 2015, In : The Diabetes educator. 41, p. 32S-46S

Research output: Contribution to journalArticle

7 Scopus citations
84 Scopus citations
2014
5 Scopus citations
7 Scopus citations

Nephropathy in youth and young adults with type 2 diabetes.

Solis-Herrera, C., Triplitt, C. L. & Lynch, J. L., 2014, In : Current Diabetes Reports. 14, 2, p. 456 1 p.

Research output: Contribution to journalArticle

12 Scopus citations
2013

Mechanisms of glucose lowering of dipeptidyl peptidase-4 inhibitor sitagliptin when used alone or with metformin in type 2 diabetes: A double-tracer study

Solis-Herrera, C., Triplitt, C., De Jesús Garduno-Garcia, J., Adams, J., Defronzo, R. A. & Cersosimo, E., Sep 1 2013, In : Diabetes care. 36, 9, p. 2756-2762 7 p.

Research output: Contribution to journalArticle

35 Scopus citations
2012

Managing Diabetes in Patients With Diabetes of Long Duration

Triplitt, C. L., Jul 2012, In : The Diabetes Educator. 38, p. 23S-30S

Research output: Contribution to journalArticle

3 Scopus citations
2011

Effect of exenatide on splanchnic and peripheral glucose metabolism in type 2 diabetic subjects

Cersosimo, E., Gastaldelli, A., Cervera, A., Wajcberg, E., Sriwijilkamol, A., Fernandez, M., Zuo, P., Petz, R., Triplitt, C., Musi, N. & DeFronzo, R. A., Jun 2011, In : Journal of Clinical Endocrinology and Metabolism. 96, 6, p. 1763-1770 8 p.

Research output: Contribution to journalArticle

34 Scopus citations

Effects of insulin and oral anti-diabetic agents on glucose metabolism, vascular dysfunction and skeletal muscle inflammation in type 2 diabetic subjects

Joya-Galeana, J., Fernandez, M., Cervera, A., Reyna, S., Ghosh, S., Triplitt, C., Musi, N., Defronzo, R. A. & Cersosimo, E., May 1 2011, In : Diabetes/Metabolism Research and Reviews. 27, 4, p. 373-382 10 p.

Research output: Contribution to journalArticle

19 Scopus citations

Metabolic effects of muraglitazar in type 2 diabetic subjects

Fernandez, M., Gastaldelli, A., Triplitt, C., Hardies, J., Casolaro, A., Petz, R., Tantiwong, P., Musi, N., Cersosimo, E., Ferrannini, E. & DeFronzo, R. A., Oct 2011, In : Diabetes, Obesity and Metabolism. 13, 10, p. 893-902 10 p.

Research output: Contribution to journalArticle

10 Scopus citations
2010

Effects of exenatide plus rosiglitazone on β-cell function and insulin sensitivity in subjects with type 2 diabetes on metformin

DeFronzo, R. A., Triplitt, C., Qu, Y., Lewis, M. S., Maggs, D. & Glass, L. C., May 1 2010, In : Diabetes care. 33, 5, p. 951-957 7 p.

Research output: Contribution to journalArticle

82 Scopus citations
2009

Pharmacist scope of practice, standards of practice, and standards of professional performance for diabetes educators

Shane-McWhorter, L., Armor, B., Johnson, J. T., Letassy, N., Reichert, S. L., Sisson, E. M., Hanson, J. B. S., Triplett, C. & Vivian, E. M., May 1 2009, In : Diabetes Educator. 35, SUPPL. 3, p. 69S-84S

Research output: Contribution to journalArticle

6 Scopus citations
2008

Addition of pioglitazone and ramipril to intensive insulin therapy in type 2 diabetic patients improves vascular dysfunction by different mechanisms

Fernandez, M., Triplitt, C., Wajcberg, E., Sriwijilkamol, A. A., Musi, N., Cusi, K., DeFronzo, R. & Cersosimo, E., Jan 1 2008, In : Diabetes care. 31, 1, p. 121-127 7 p.

Research output: Contribution to journalArticle

31 Scopus citations

Best practices for lowering the risk of cardiovascular disease in diabetes

Triplitt, C. & Alvarez, C. A., Jun 1 2008, In : Diabetes Spectrum. 21, 3, p. 177-189 13 p.

Research output: Contribution to journalArticle

5 Scopus citations

Mechanism of action of exenatide to reduce postprandial hyperglycemia in type 2 diabetes

Cervera, A., Wajcberg, E., Sriwijitkamol, A., Fernandez, M., Zuo, P., Triplitt, C., Musi, N., DeFronzo, R. A. & Cersosimo, E., May 1 2008, In : American Journal of Physiology - Endocrinology and Metabolism. 294, 5, p. E846-E852

Research output: Contribution to journalArticle

131 Scopus citations

Physiological and molecular determinants of insulin action in the baboon

Chavez, A. O., Lopez-Alvarenga, J. C., Tejero, M. E., Triplitt, C., Bastarrachea, R. A., Sriwijitkamol, A., Tantiwong, P., Voruganti, V. S., Musi, N., Comuzzie, A. G., Defronzo, R. A. & Folli, F., Apr 1 2008, In : Diabetes. 57, 4, p. 899-908 10 p.

Research output: Contribution to journalArticle

64 Scopus citations
2007

First approved inhaled insulin therapy for diabetes mellitus

Jani, R., Triplitt, C., Reasner, C. & DeFronzo, R. A., Jan 1 2007, In : Expert Opinion on Drug Delivery. 4, 1, p. 63-76 14 p.

Research output: Contribution to journalArticle

15 Scopus citations

How to initiate, titrate, and intensify insulin treatment in type 2 diabetes

Triplitt, C., Oct 18 2007, U.S. Pharmacist, 32, 10, p. 10-16 7 p.

Research output: Contribution to specialist publicationArticle

3 Scopus citations

Rosiglitazone decreases albuminuria in type 2 diabetic patients

Miyazaki, Y., Cersosimo, E., Triplitt, C. & DeFronzo, R. A., Dec 2007, In : Kidney international. 72, 11, p. 1367-1373 7 p.

Research output: Contribution to journalArticle

89 Scopus citations
2006

Comparison of glargine insulin versus rosiglitazone addition in poorly controlled type 2 diabetic patients on metformin plus sulfonylurea

Triplitt, C., Glass, L., Miyazaki, Y., Wajcberg, E., Gastaldelli, A., De Filippis, E., Cersosimo, E. & DeFronzo, R. A., Nov 1 2006, In : Diabetes care. 29, 11, p. 2371-2377 7 p.

Research output: Contribution to journalArticle

18 Scopus citations
2005

Predictors of improved glycaemic control with rosiglitazone therapy in type 2 diabetic patients: A practical approach for the primary care physician

Miyazaki, Y., De Filippis, E., Bajaj, M., Wajcberg, E., Glass, L., Triplitt, C., Cersosimo, E., Mandarino, L. J. & DeFronzo, R. A., Jan 1 2005, In : British Journal of Diabetes and Vascular Disease. 5, 1, p. 28-35 8 p.

Research output: Contribution to journalArticle

15 Scopus citations
2004

Dose-response effect of a single administration of oral hexyl-insulin monoconjugate 2 in healthy nondiabetic subjects

Wajcberg, E., Miyazaki, Y., Triplitt, C., Cersosimo, E. & DeFronzo, R. A., Dec 1 2004, In : Diabetes care. 27, 12, p. 2868-2873 6 p.

Research output: Contribution to journalArticle

27 Scopus citations
2002

Abdominal fat distribution and peripheral and hepatic insulin resistance in type 2 diabetes mellitus

Miyazaki, Y., Glass, L., Triplitt, C., Wajcberg, E., Mandarino, L. J. & DeFronzo, R. A., Dec 1 2002, In : American Journal of Physiology - Endocrinology and Metabolism. 283, 6 46-6, p. E1135-E1143

Research output: Contribution to journalArticle

189 Scopus citations
2001

Effect of rosiglitazone on glucose and non-esterified fatty acid metabolism in Type II diabetic patients

Miyazaki, Y., Glass, L., Triplitt, C., Matsuda, M., Cusi, K., Mahankali, A., Mahankali, S., Mandarino, L. J. & DeFronzo, R. A., Dec 1 2001, In : Diabetologia. 44, 12, p. 2210-2219 10 p.

Research output: Contribution to journalArticle

231 Scopus citations